Put Your Treatment for Mouth or Throat Cancer through Clinical Trials with Worldwide
According to the Oral Cancer Foundation, the incidence of oral and oropharyngeal cancers has been increasing over the last decade. Today, more than 50,000 people in the United States are diagnosed with some sort of mouth or throat cancer each year, and worldwide, the number is more than 640,000 cases per year. Heavy smoking and heavy drinking have long been recognized as risk factors contributing to the development of oral cancers, but an increasing incidence of oral cancers appears to be associated with exposure to the human papillomavirus (HPV) through oral sex.
The prognosis for individuals diagnosed with oral cancer is generally good if the cancer is detected early. If detected in later stages, the prognosis declines. Moreover, the protocols for treatment of more advanced cancers can be much more traumatic for the patient – involving not only radiation and chemotherapies but also faciomaxillary reconstruction if portions of the mouth or throat need to be surgically removed.
Researchers working in the oral cancer field know both the demand for treatments and the hurdles involved in bringing a treatment to market. Helping you overcome the latter, specifically in the realm of clinical trials, is the role of Worldwide Clinical Trials.
Worldwide has internationally acclaimed expertise in clinical trial management. We offer full-service support for Phase I-Phase IV clinical trials, as well as real-world evidence studies that can help you understand the effects of your work on oral cancers over both the short and long term. We have been supporting oncology researchers for more than 30 years, and our global footprint ensures that you will be able to build out the trials most appropriate for your work, your budget, and the regulatory requirements governing your efforts.
When you’re ready to take the next step, let the experts at Worldwide help you.